SpacePharma

SpacePharma is a technology provider specialising in microgravity research services for the pharmaceutical, biotechnology, and materials science sectors. The organisation designs and operates miniaturised, automated laboratory systems that function in low Earth orbit, allowing for experiments that are unencumbered by gravity-driven convection or sedimentation. By providing end-to-end mission support, the company bridges the gap between terrestrial research facilities and orbital platforms, occupying a niche in the commercial space-for-earth value chain. The organisation has conducted multiple missions using its DIDO series of nanosatellites and has deployed laboratory modules to the International Space Station. Its customer base includes commercial drug developers and academic institutions seeking to observe complex molecular structures and protein crystallisation in a weightless environment. Key operational partners include the European Space Agency and the Israel Space Agency, who have supported various orbital campaigns for chemical and biological validation. Prospective partners should verify the specific technical readiness levels of the lab-on-a-chip interfaces intended for their research payloads. It is essential to confirm the current availability of flight opportunities, including lead times for integration and the specific downlink capabilities for real-time telemetry. Buyers should also evaluate the regulatory compliance of their biological samples regarding international space station safety protocols and export control regulations.